Atlas Trials

Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain Metastases

Clinical trial NCT05638425 · UNKNOWN

Trial details

NCT number
NCT05638425
Sponsor
Xiangya Hospital of Central South University
Status
UNKNOWN
Study type
OBSERVATIONAL
Non-small Cell Lung Cancer MetastaticBrain Metastases
Start date
2021-12-31
Primary completion
2023-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.